Related Experiment Video
Updated: Sep 27, 2026
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Regulation of microglia - potential new drug targets in the CNS
1Department of Neuroscience, Biomedical Center, PO Box 587, SE-751 23 Uppsala, Sweden. Hakan.Aldskogius@neuro.uu.se
Abstract:
Microglia respond to any disturbance in the CNS which poses a threat to physiological homeostasis. Although these responses are secondary, mainly to neuronal alterations, the way the microglial response evolves in many situations promotes further damage to the CNS. The list of clinical conditions in which this situation is a major problem is continuously growing and includes neurodegenerative diseases, stroke, trauma, demyelinating disorders and neuropathic pain. The significance of microglia for the pathogenesis of neurological and neuropsychiatric conditions has led to a rapidly expanding search for therapeutic possibilities to regulate microglial activity. As will be clear from this review, treatments which are currently available appear to offer some positive effects but are still far from satisfactory. A major challenge is to understand the mechanisms that determine whether activated microglia will develop into a cytotoxic or a cytoprotective component.
Insights
Microglia, the brain's immune cells, can worsen CNS damage when activated. Understanding how to control their response is key for treating neurological disorders.
Area of Science:
- Neuroscience
- Immunology
- Cellular Biology
Background:
- Microglia are central nervous system (CNS) immune cells that respond to disturbances.
- Microglial activation, while secondary to neuronal changes, can exacerbate CNS damage.
- This detrimental role is implicated in neurodegenerative diseases, stroke, trauma, demyelinating disorders, and neuropathic pain.
Purpose of the Study:
- To review the role of microglia in CNS pathogenesis.
- To explore therapeutic strategies for modulating microglial activity.
- To identify mechanisms determining cytotoxic versus cytoprotective microglial phenotypes.
Main Methods:
- This is a review article, synthesizing existing research on microglia.
- Literature search and analysis of studies investigating microglial responses in various CNS conditions.
- Examination of therapeutic interventions targeting microglial pathways.
Main Results:
- Microglial activation is a significant factor in the progression of numerous neurological and neuropsychiatric conditions.
- Current treatments offer limited efficacy in managing microglial-mediated damage.
- A critical knowledge gap exists in understanding the regulatory mechanisms of microglial phenotype.
Conclusions:
- Microglia play a pivotal role in CNS injury and disease.
- Effective therapeutic strategies require a deeper understanding of microglial activation states.
- Targeting microglial pathways holds promise for novel treatments, but current options are insufficient.
